Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Clinical trial NCT03710772 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03710772
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2027-03-22
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.